Verition Fund Management LLC - REATA PHARMACEUTICALS INC ownership

Back to all holdings Add to watchlist

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 152 filers reported holding REATA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 3.61 and the average weighting 0.2%.

Links
Filings
External links
Quarter-by-quarter ownership
Verition Fund Management LLC ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$588,411
+12.1%
5,7710.0%0.01%
+14.3%
Q1 2023$524,699
-80.7%
5,771
-93.1%
0.01%
-78.8%
Q1 2022$2,724,000–83,158–0.03%–
 Download
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
DekaBank Deutsche Girozentrale 17,000$2,9300.01%
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO 93,711$1,6120.00%
IFP Advisors, Inc 300$51,7080.00%
View complete list of REATA PHARMACEUTICALS INC shareholders